Search NLS News

The company's Board of Directors has appointed Johan Liwing as the new Chief Executive Officer.

Medivir has announced the approval of the US Investigational New Drug application (IND) for evaluating fostrox + Lenvima vs Lenvima alone in a phase 2b study in 2nd line advanced HCC.

Orexo has entered into a settlement agreement with Sun Pharmaceuticals Industries to resolve the patent litigation regarding Zubsolv (buprenorphine and naloxone) sublingual tablet (CIII), for the treatment of opioid use disorder in the US.

The Swedish government has presented the research and innovation bill, which sets out the direction of the government's policy in the area for the next four years.

Vicore Pharma is praised for being at the forefront of addressing unmet medical needs in rare diseases and for securing one of Sweden’s largest biotech raises in 2024.

The company is preparing to launch a phase II clinical trial in pancreatic cancer with funds from a recent private placement.

SwedenBIO, the industry organization for Sweden's life science companies, presented on December 11th 2024 its Life Science Barometer 2025.

Accumulus Synergy’s cloud-based data-sharing platform could accelerate access to vaccines and other health technologies by enabling multi-country regulatory submissions and expediting regulatory review and approval, potentially helping to end future emerging infectious disease outbreaks swiftly and more equitably.

Sir Demis Hassabis, co-founder and CEO of Google DeepMind and Isomorphic Labs, and John Jumper, Director and Senior Research Scientist at Google DeepMind, have been honored with the 2024 Nobel Prize in Chemistry for their revolutionary technology for predicting the 3D structure of proteins.

Oskar Hansson is professor of neurology and research group leader for the clinical memory research unit at Lund University.